2024
Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options
Mestre-Bach G, Potenza M. Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options. CNS Drugs 2024, 38: 255-265. PMID: 38485889, DOI: 10.1007/s40263-024-01075-2.Peer-Reviewed Original ResearchMeSH KeywordsCompulsive BehaviorFluoxetineHumansParoxetineSelective Serotonin Reuptake InhibitorsSertralineConceptsCompulsive sexual behavior disorderSexual behavior disorderReuptake inhibitorsBehavioral disordersPornography usePharmacological treatmentCo-occurring disordersEmpirical supportSerotonin reuptake inhibitorsCo-occurring conditionsMood stabilizersPsychiatric disordersPsychological therapiesTricyclic antidepressantsGeneralizability of resultsOpioid antagonistSerotonin antagonistsDisordersSerotoninPharmacological optionsPharmacological approachesAntagonistPharmacological therapyNarrative reviewNefazodone
1998
Olanzapine Augmentation of Fluoxetine in the Treatment of Refractory Obsessive-Compulsive Disorder
Potenza M, Wasylink S, Longhurst J, Epperson C, McDougle C. Olanzapine Augmentation of Fluoxetine in the Treatment of Refractory Obsessive-Compulsive Disorder. Journal Of Clinical Psychopharmacology 1998, 18: 423-424.. PMID: 9790164, DOI: 10.1097/00004714-199810000-00014.Peer-Reviewed Original ResearchOlanzapine Augmentation of Fluoxetine in the Treatment of Trichotillomania
POTENZA M, WASYLINK S, EPPERSON C, MCDOUGLE C. Olanzapine Augmentation of Fluoxetine in the Treatment of Trichotillomania. American Journal Of Psychiatry 1998, 155: 1299a-1300. PMID: 9734562, DOI: 10.1176/ajp.155.9.1299a.Peer-Reviewed Original Research